| 0.5701 -0.05 (-8.05%) | 04-25 10:22 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.86 | 1-year : | 1 |
| Resists | First : | 0.73 | Second : | 0.86 |
| Pivot price | 0.5  |
|||
| Supports | First : | 0.48 | Second : | 0.33 |
| MAs | MA(5) : | 0.61 |
MA(20) : | 0.5 |
| MA(100) : | 2.11 |
MA(250) : | 2.59 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 73.7 |
D(3) : | 75.3 |
| RSI | RSI(14): 47 |
|||
| 52-week | High : | 5.38 | Low : | 0.33 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ KA ] has closed below upper band by 23.2%. Bollinger Bands are 61.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.67 - 0.67 | 0.67 - 0.68 |
| Low: | 0.59 - 0.6 | 0.6 - 0.6 |
| Close: | 0.61 - 0.62 | 0.62 - 0.62 |
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Thu, 25 Apr 2024
Kineta (NASDAQ:KA) Stock Price Down 7.4% - Defense World
Fri, 19 Apr 2024
Market Insights: Kineta Inc (KA)'s Notable Gain of 3.43, Closing at 0.49 – DWinneX - The Dwinnex
Sat, 06 Apr 2024
Antibe Therapeutics (OTCMKTS:ATBPD) & Kineta (NASDAQ:KA) Critical Contrast - Defense World
Tue, 05 Mar 2024
KA Stock Quote Price and Forecast - CNN
Thu, 29 Feb 2024
Kineta Weighs Strategic Alternatives Amid Operational Challenges - TipRanks.com - TipRanks
Thu, 29 Feb 2024
Healthcare Stocks on the Move Thursday: LVTX, SCTL, ENVB, RNLX, KA, IRWD, AMPE, GRFS - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 11 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 29.2 (%) |
| Held by Institutions | 12 (%) |
| Shares Short | 62 (K) |
| Shares Short P.Month | 20 (K) |
| EPS | -1.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.28 |
| Profit Margin | -259.1 % |
| Operating Margin | -289 % |
| Return on Assets (ttm) | -71 % |
| Return on Equity (ttm) | -369.1 % |
| Qtrly Rev. Growth | -100 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.49 |
| EBITDA (p.s.) | -1.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -16 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.48 |
| PEG Ratio | 0 |
| Price to Book value | 2.17 |
| Price to Sales | 1.22 |
| Price to Cash Flow | -0.42 |
| Dividend | 10.01 |
| Forward Dividend | 0 |
| Dividend Yield | 1640.9% |
| Dividend Pay Date | 2000-01-10 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|